Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  PAREXEL International Corporation    PRXL

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. engages in the provision of clinical research, medical communications, consulting, commercialization and informatics, and technology services to pharmaceutical, biotechnology, and medical device industries.

It operates through the following segments: Clinical Research Services, PAREXEL Consulting Services and PAREXEL Informatics.

The Clinical Research Services segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, date management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, clinical pharmacology, and related medical affairs, patient recruitment and investigator site services.

The PAREXEL Consulting Services segment provides technical expertise and advice in drug development, regulatory affairs, and good manufacturing practice compliance consulting.

The PAREXEL Informatics segment provides information technology solutions designed to improve client's product development processes.

The company was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.

Number of employees : 18 600 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Clinical Research Services1,53565.8%1,62667% +5.9%
PAREXEL Informatics264.6711.3%277.9011.4% +5%
PAREXEL Consulting Services215.959.3%190.407.8% -11.83%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States984.6842.2%908.9037.4% -7.7%
Europe, Middle East & Africa451.4619.4%568.1023.4% +25.84%
Asia/Pacific269.3011.5%296.7012.2% +10.18%
United Kingdom239.6510.3%251.0010.3% +4.74%
Americas70.903%69.602.9% -1.83%
Managers
NameAgeSinceTitle
Josef H. von Rickenbach, MBA611983Chairman & Chief Executive Officer
Mark A. Goldberg, MD551997President & Chief Operating Officer
Emma Reeve552014CFO, Principal Accounting Officer, VP & Controller
Sy Pretorius MD, MBA--Chief Scientific Officer & Vice President
A. Dana Callow Jr., MBA641986Independent Director
Patrick J. Fortune PhD, MBA691996Independent Director
Richard L. Love722002Independent Director
Ellen M. Zane642006Independent Director
Christopher J. Lindop, CPA572006Independent Director
Eduard Enrico Holdener, MD702008Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 53,267,019 52,247,908 98.1% 0 0.0% 98.1%
Shareholders
NameEquities%
BlackRock Fund Advisors 4,623,668 8.66%
The Vanguard Group, Inc. 4,495,778 8.42%
UBS Financial Services, Inc. 3,103,215 5.81%
Fisher Asset Management LLC 2,312,019 4.33%
SSgA Funds Management, Inc. 1,681,773 3.15%
Wellington Management Co. LLP 1,671,513 3.13%
Neuberger Berman Investment Advisers LLC 1,353,313 2.53%
Frontier Capital Management Co. LLC 1,196,943 2.24%
Aberdeen Asset Managers Ltd. 1,113,671 2.09%
Northern Trust Investments, Inc. 990,625 1.85%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
PAREXEL INTERNATIONAL ..-14.06%3 129
INCYTE CORPORATION-7.86%19 219
QUINTILES IMS HOLDINGS..6.32%18 225
CELLTRION, INC.--.--%9 953
SEATTLE GENETICS, INC.48.64%9 442
LONZA GROUP AG11.34%9 247
ALKERMES PLC-29.14%8 548
QIAGEN NV-2.75%6 542
UNITED THERAPEUTICS CO..-19.23%5 365
IONIS PHARMACEUTICALS ..-30.57%5 212
ICON PLC-3.15%4 173
BIO-TECHNE CORP17.11%3 932
ALNYLAM PHARMACEUTICAL..-55.83%3 567
CHARLES RIVER LABORATO..-12.90%3 402
INTREXON CORP-6.20%3 353
ACADIA PHARMACEUTICALS..-25.72%3 288
PRA HEALTH SCIENCES IN..14.87%3 228
BB BIOTECH AG-8.81%2 906
GALAPAGOS-2.96%2 716
INC RESEARCH HOLDINGS ..0.49%2 614
IRONWOOD PHARMACEUTICA..31.23%2 268
Sector Biotechnology & Medical Research - NEC
PAREXEL International Corp : Connections
PAREXEL International Corp.
195 West Street
Waltham, MA 02451

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
© 2016 People , Fundamentals and Ownership